TY  - RPRT
TI  - A First-in-Japanese Phase 1, Double-Blind, Placebo-Controlled, Parallel-Cohort Study of Sefaxersen, an Antisense Oligonucleotide Targeting Complement Factor B, in Healthy Participants.
AU  - Takakazu Sato
AU  - Hiroyuki Fukase
AU  - Takaaki Ishida
AU  - Arisa Karasawa
PY  - 2026
DO  - 10.1002/cpdd.70097
UR  - https://pubmed.ncbi.nlm.nih.gov/42713733/
ID  - 42713733
ER  -